0001179110-22-003137.txt : 20220525
0001179110-22-003137.hdr.sgml : 20220525
20220525165803
ACCESSION NUMBER: 0001179110-22-003137
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220523
FILED AS OF DATE: 20220525
DATE AS OF CHANGE: 20220525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SEVERINO MICHAEL
CENTRAL INDEX KEY: 0001609447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 22963844
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2022-05-23
0
0001551152
AbbVie Inc.
ABBV
0001609447
SEVERINO MICHAEL
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
Vice Chairman
Common Stock, $0.01 par value
2022-05-23
4
M
0
46320
114.36
A
198423
D
Common Stock, $0.01 par value
2022-05-23
4
M
0
11742
93.50
A
210165
D
Common Stock, $0.01 par value
2022-05-23
4
M
0
21739
105.92
A
231904
D
Common Stock, $0.01 par value
2022-05-23
4
S
0
68196
150.79
D
163708
D
Common Stock, $0.01 par value
2022-05-23
4
S
0
11605
151.53
D
152103
D
Option (Right to Buy)
114.36
2022-05-23
4
M
0
46320
114.36
D
2019-02-15
2028-02-14
Common Stock
46320
0
D
Option (Right to Buy)
93.50
2022-05-23
4
M
0
11742
93.50
D
2021-02-20
2030-02-19
Common Stock
11742
38188
D
Option (Right to Buy)
105.92
2022-05-23
4
M
0
21739
105.92
D
2022-02-18
2031-02-17
Common Stock
21739
43478
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.13 to $151.12 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.13 to $151.58 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Steven L. Scrogham, attorney-in-fact for Michael Severino
2022-05-25